BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20955461)

  • 21. Invasive Haemophilus influenzae type b disease in Sweden 1997-2003: epidemiological trends and patterns in the post-vaccine era.
    Farhoudi D; Löfdahl M; Giesecke J
    Scand J Infect Dis; 2005; 37(10):717-22. PubMed ID: 16191888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
    Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.
    Ladhani S; Ramsay M; Flood J; Campbell H; Slack M; Pebody R; Findlow J; Newton E; Wilding M; Warrington R; Crawford H; Min S; Gray K; Martin S; Frankland S; Bokuvha N; Laher G; Borrow R
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.
    Omeñaca F; Garcia-Sicilia J; Boceta R; Sistiaga-Hernando A; García-Corbeira P
    Pediatr Infect Dis J; 2007 Sep; 26(9):824-9. PubMed ID: 17721379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
    Zarei AE; Redwan EM
    Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules.
    Hong E; Terrade A; Denizon M; Aouiti-Trabelsi M; Falguières M; Taha MK; Deghmane AE
    BMC Infect Dis; 2021 Jul; 21(1):715. PubMed ID: 34330228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
    Massó F; Paéz A; Arista A; Salmón L; Montaño L
    Arch Med Res; 1996; 27(4):539-45. PubMed ID: 8987192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom.
    Ladhani S; Heath PT; Ramsay ME; Slack MP; Kibwana E; Pollard AJ; Booy R
    Clin Infect Dis; 2009 Aug; 49(3):372-80. PubMed ID: 19580418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants.
    Breukels MA; Spanjaard L; Sanders LA; Rijkers GT
    Clin Infect Dis; 2001 Jun; 32(12):1700-5. PubMed ID: 11360210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines.
    Huebner RE; Nicol M; Mothupi R; Käyhty H; Mbelle N; Khomo E; Klugman KP
    Vaccine; 2004 Dec; 23(6):802-6. PubMed ID: 15542205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales.
    Collins S; Litt D; Almond R; Findlow J; Linley E; Ramsay M; Borrow R; Ladhani S
    J Infect; 2018 Apr; 76(4):335-341. PubMed ID: 29289561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign.
    Ladhani S; Slack MP; Heys M; White J; Ramsay ME
    Arch Dis Child; 2008 Aug; 93(8):665-9. PubMed ID: 17942585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
    Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
    Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB; Moggio MV; Drucker RP; Wilfert CM
    Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
    Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L
    Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemophilus influenzae type b reemergence after combination immunization.
    Johnson NG; Ruggeberg JU; Balfour GF; Lee YC; Liddy H; Irving D; Sheldon J; Slack MP; Pollard AJ; Heath PT
    Emerg Infect Dis; 2006 Jun; 12(6):937-41. PubMed ID: 16707049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.
    Ladhani SN
    Clin Ther; 2012 Feb; 34(2):385-99. PubMed ID: 22244051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.